Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Lack of association between CDKN2A germline mutations and survival in patients with melanoma: A retrospective cohort study.

Journal of the American Academy of Dermatology - 1 Aug 2022

Ipenburg Norbertus Anton, El Sharouni Mary-Ann, van Doorn Remco, van Diest Paul J, van Leerdam Monique E, van der Rhee Jasper I, Goeman Jelle, Kukutsch Nicole A

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cyclin-Dependent Kinase Inhibitor p16
Share to Genes, p16
Share to Genetic Predisposition to Disease

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Germ-Line Mutation

Share to Melanoma

Share to Pedigree

Share to Skin Neoplasms

Source

Identifiers

PMID: 34695526
DOI: 10.1016/j.jaad.2021.10.024

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Lack of association between CDKN2A germline mutations and survival in patients with melanoma: A retrospective cohort study.PMID 34695526Read ↗

CDKN2 mutations in melanoma.Semantic proximity Read ↗

Prognosis of CDKN2A germline mutation in patients with familial melanoma: a systematic review and meta-analysis.Semantic proximity Read ↗

Phenotypic and Histopathological Tumor Characteristics According to CDKN2A Mutation Status among Affected Members of Melanoma Families.Semantic proximity Read ↗

Low prevalence of germline CDKN2A and CDK4 mutations in patients with early-onset melanoma.Semantic proximity Read ↗

Germline mutations in CDKN2A are infrequent in female patients with melanoma and breast cancer.Semantic proximity Read ↗

Noncoding germline mutations in p16/CDKN2A in melanoma-prone families.Semantic proximity Read ↗

Familial features affecting the melanoma risk in CDKN2A-negative melanoma families: a study based on the Swedish Cancer Registry.Semantic proximity Read ↗

Germline<i>CDKN2A</i>Mutation Status and Survival in Familial Melanoma CasesSemantic proximity Read ↗

CDKN2A/CDK4 status in Brazilian patients meeting clinical criteria for hereditary melanoma: a cross-sectional descriptive trial.Semantic proximity Read ↗

Prevalence and predictors of germline CDKN2A mutations for melanoma cases from Australia, Spain and the United KingdomSemantic proximity Read ↗

American Academy of Dermatology 1999 Awards for Young Investigators in Dermatology. The prevalence of CDKN2A in patients with atypical nevi and malignant melanoma.Semantic proximity Read ↗

Clinical germline genetic testing for melanoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.